Eurizon Capital SGR S.p.A.

Position in ABT — Abbott Laboratories

CIK 2107286 MILAN, L6

Position in ABT

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$80,305,599

-$12,358,509 QoQ

Shares Held

782,172

+5.8% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 81.41240034161285.ToString("F0")% Shared 0.ToString("F0")% None 18.58759965838716.ToString("F0")%

Healthcare · as of Mar 31, 2026

Eurizon Capital SGR S.p.A. holds $336,008,537 across 21 Medical Devices names. ABT ranks #2 (23.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	1,348,483	$84,617,308
2	ABT	Abbott Laboratories This page	782,172	$80,305,599
3	MDT	Medtronic plc	836,290	$72,464,528
4	GEHC	GE HealthCare Technologies Inc.	307,025	$21,854,039
5	SYK	Stryker Corp	61,634	$20,252,316
6	ZBH	Zimmer Biomet Holdings, Inc.	179,246	$16,207,423
7	STE	STERIS plc	66,455	$14,695,194
8	EW	Edwards Lifesciences Corp	153,537	$12,295,242

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$80,305,599	782,172	+5.8%	Shares	Other	2026-05-08
2025-12-31	$92,664,108	739,597	—	Shares	Other	2026-02-10
No filing history on record for this holder in this stock.